Literature DB >> 18159477

Invasive Streptococcus pneumoniae infection causing hemolytic uremic syndrome in children: Two recent cases.

Otto G Vanderkooi1, James D Kellner, Andrew W Wade, Tajdin Jadavji, Julian P Midgley, Thomas Louie, Gregory J Tyrell.   

Abstract

INTRODUCTION: Streptococcus pneumoniae is an uncommon cause of hemolytic uremic syndrome (HUS) with a unique pathophysiology that differs from Shiga toxin-related HUS.
METHODS: Case descriptions for each patient are provided. Each strain of S pneumoniae was subjected to a pulsed-field gel electrophoresis (PFGE) analysis, Shiga toxin assay and polymerase chain reaction to detect Shiga toxin genes. A review of the current literature was conducted. CASE PRESENTATIONS: Two patients with S pneumoniae-related HUS that presented to the Alberta Children's Hospital, Calgary, Alberta, within four weeks of each other in 2001 are described. Both presented with pneumonia and empyema with associated HUS. Both patients required dialysis, one patient for 10 days and the other for 18 days. Neither patient demonstrated evidence of Shiga toxin-related disease. S pneumoniae isolated from blood or pleural fluid was penicillin susceptible. One isolate was serotype 3 and the other was serotype 14. The two strains had different PFGE patterns. Both patients recovered well with no persistent renal dysfunction.
CONCLUSIONS: S pneumoniaecontinues to be an uncommon but important cause of HUS. Most cases can be confirmed or at least considered probable without performing a renal biopsy.

Entities:  

Keywords:  Hemolytic uremic syndrome; Streptococcus pneumoniae

Year:  2003        PMID: 18159477      PMCID: PMC2094953          DOI: 10.1155/2003/219027

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  44 in total

1.  Prognosis of Streptococcus pneumoniae-induced hemolytic uremic syndrome.

Authors:  S Nathanson; G Deschênes
Journal:  Pediatr Nephrol       Date:  2001-04       Impact factor: 3.714

Review 2.  The pathogenesis and treatment of hemolytic uremic syndrome.

Authors:  B S Kaplan; K E Meyers; S L Schulman
Journal:  J Am Soc Nephrol       Date:  1998-06       Impact factor: 10.121

Review 3.  Pneumococcal meningitis complicated with hemolytic uremic syndrome: report of two cases.

Authors:  F Y Huang; D S Lin
Journal:  Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi       Date:  1998 Jan-Feb

4.  Histochemical demonstration of neuraminidase effects in pneumococcal meningitis.

Authors:  M Vierbuchen; P J Klein
Journal:  Lab Invest       Date:  1983-02       Impact factor: 5.662

5.  Lectin binding sites in the choroid plexus and choroid plexus papillomas.

Authors:  W Müller; P J Klein; M J Vierbuchen; G Uhlenbruck
Journal:  Neurosurg Rev       Date:  1980       Impact factor: 3.042

6.  Nature of human serum blood group T antibodies.

Authors:  Y D Kim; U Prakash; G F Weber; M Hargie
Journal:  Immunol Commun       Date:  1979

7.  Haemolytic uraemic syndrome and the Thomsen Friedenreich antigen.

Authors:  M E McGraw; M Lendon; R F Stevens; R J Postlethwaite; C M Taylor
Journal:  Pediatr Nephrol       Date:  1989-04       Impact factor: 3.714

8.  Hemolytic-uremic syndrome: an analysis of the natural history and prognostic features.

Authors:  C Loirat; E Sonsino; A Varga Moreno; G Pillion; J C Mercier; F Beaufils; H Mathieu
Journal:  Acta Paediatr Scand       Date:  1984-07

9.  [Pathomorphology of pneumococcal infection in children].

Authors:  L S Khodasevich; A Iu Val'kov
Journal:  Arkh Patol       Date:  1998 May-Jun

10.  Haemolytic-uraemic syndrome associated with Streptococcus pneumoniae meningitis.

Authors:  A Martinot; V Hue; F Leclerc; M Chenaud
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

View more
  2 in total

Review 1.  Streptococcus Pneumoniae-Associated Hemolytic Uremic Syndrome in the Era of Pneumococcal Vaccine.

Authors:  Hemant S Agarwal; Samir Q Latifi
Journal:  Pathogens       Date:  2021-06-09

Review 2.  Streptococcus pneumoniae-associated hemolytic uremic syndrome.

Authors:  Lawrence Copelovitch; Bernard S Kaplan
Journal:  Pediatr Nephrol       Date:  2007-06-13       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.